Your browser doesn't support javascript.
loading
Efficacy of nano-particulated, water-soluble erlotinib against intracranial metastases of EGFR-mutant lung cancer.
Kim, Dong Ha; Choi, Yun Jung; Sung, Ki Jung; Yoo, Seon-A; Sung, Young Hoon; Kim, Jeong Kon; Choi, Chang-Min; Yun, Miyong; Lee, Eun Yong; Jin, Yong Suk; Cook, Seungho; Rho, Jin Kyung; Lee, Jae Cheol.
Afiliação
  • Kim DH; Department of Pulmonology and Critical Care Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea.
  • Choi YJ; Asan Institute for Life Sciences, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea.
  • Sung KJ; Department of Pulmonology and Critical Care Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea.
  • Yoo SA; Asan Institute for Life Sciences, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea.
  • Sung YH; Department of Pulmonology and Critical Care Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea.
  • Kim JK; Asan Institute for Life Sciences, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea.
  • Choi CM; Department of Pulmonology and Critical Care Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea.
  • Yun M; Asan Institute for Life Sciences, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea.
  • Lee EY; Asan Institute for Life Sciences, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea.
  • Jin YS; Department of Convergence Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea.
  • Cook S; Department of Radiology, Research Institute of Radiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea.
  • Rho JK; Department of Pulmonology and Critical Care Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea.
  • Lee JC; Department of Oncology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea.
Mol Oncol ; 12(12): 2182-2190, 2018 12.
Article em En | MEDLINE | ID: mdl-30350450
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Hidroterapia Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Receptores ErbB / Cloridrato de Erlotinib / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Oncol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Coréia do Sul
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Hidroterapia Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Receptores ErbB / Cloridrato de Erlotinib / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Oncol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Coréia do Sul